Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Orix ADR | IX | 8. oct 2024 | 112.81 | -1.34 |
Orla Mining | ORLA | 8. oct 2024 | 4.15 | -0.24 |
Ormat Technologies | ORA | 8. oct 2024 | 75.27 | -0.83 |
Orrstown Financial Services | ORRF | 8. oct 2024 | 34.80 | -0.20 |
Orthofix Medical | OFIX | 8. oct 2024 | 15.10 | +0.07 |
OrthoPediatrics | KIDS | 8. oct 2024 | 24.50 | -0.81 |
Oruka Therapeutics | ORKA | 8. oct 2024 | 27.51 | 0.00 |
OS Therapies | OSTX | 8. oct 2024 | 3.15 | 0.00 |
Oscar Health A | OSCR | 8. oct 2024 | 18.28 | -1.08 |
Oshkosh | OSK | 8. oct 2024 | 100.15 | -1.47 |
OSI Systems | OSIS | 8. oct 2024 | 146.89 | +0.80 |
Osisko Development | ODV | 8. oct 2024 | 2.08 | 0.00 |
Osisko Gold Royalties | OR | 8. oct 2024 | 18.73 | +0.48 |
Ostin Technology Group | OST | 8. oct 2024 | 0.35 | -6.51 |
Otis Worldwide | OTIS | 8. oct 2024 | 101.15 | -2.76 |
Otter Tail | OTTR | 8. oct 2024 | 74.74 | -1.57 |
Ouster | OUST | 8. oct 2024 | 6.27 | -2.79 |
Outbrain | OB | 8. oct 2024 | 4.60 | -0.22 |
Outfront Media | OUT | 8. oct 2024 | 18.22 | +1.22 |
Outlook Therapeutics | OTLK | 8. oct 2024 | 5.22 | +2.15 |
Outset Medical | OM | 8. oct 2024 | 0.59 | -3.64 |
Ovid Therapeutics | OVID | 8. oct 2024 | 1.10 | -2.65 |
Ovintiv | OVV | 8. oct 2024 | 41.84 | -3.79 |
Owens & Minor | OMI | 8. oct 2024 | 13.61 | +0.29 |
Owens Corning | OC | 8. oct 2024 | 182.08 | +0.36 |
Owlet A | OWLT | 8. oct 2024 | 4.14 | -4.61 |
Oxbridge Re | OXBR | 8. oct 2024 | 2.42 | -7.28 |
Oxford Industries | OXM | 8. oct 2024 | 75.04 | -0.04 |
Oxford Lane Capital | OXLC | 8. oct 2024 | 5.29 | +0.38 |
Oxford Lane Capital 2027 Pref | OXLCP | 8. oct 2024 | 24.01 | +0.12 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.